Periodic Reporting for period 3 - SILICOFCM (In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy)

SILICOFCM project is funded from the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No 777204). The consortium consists of 14 partners representing universities, institutes, clinics and SMEs from 6 EU countries (The United Kingdom, Germany...